This announcement is a separate document:
泰格医药：关于2024年第二次临时股东大会、2024年第一次A股类别股东会议及2024年第一次H股类别股东会议取消部分议案并增加临时提案暨股东大会补充通知的公告
Tiger Pharmaceuticals: Announcement on the cancellation of some proposals and the addition of temporary proposals and supplementary notices at the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.